CERS — CERUS CORP
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1020214 ·
Last close
$1.90
Market Cap
$383.71M
52W High
$3.47
52W Low
$1.47
ADV30
2,293,004
Next earnings
2026-11-02
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 57,714,000 | 30,265,000 | 383,000 | -550,000 | 204,729,000 | 16,350,000 | 128,367,000 |
| Jun 2026 | 57,441,000 | 29,532,000 | -1,858,000 | -2,940,000 | 205,187,000 | 17,980,000 | 134,472,000 |
| Mar 2026 | 53,661,000 | 27,894,000 | -354,000 | -1,640,000 | 222,908,000 | 27,850,000 | 154,622,000 |
| Dec 2025 | 57,751,000 | 29,749,000 | -641,000 | -2,184,000 | 221,859,000 | 19,961,000 | 156,894,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$3,497,000
Investing CF
$17,940,000
Financing CF
$-21,105,000
CapEx
$-3,003,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.03
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,086,285,000
Inventory
$64,689,000
Receivables
$30,560,000
ST Investments
$40,759,000
EBIT TTM
$-236,000
Pretax Income TTM
$-7,023,000
Interest Exp TTM
$6,787,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$226,567,008
EBITDA
$-748,000
Free Cash Flow
$2,131,375
Enterprise Value
$426,459,456
Total Cash
$57,109,000
Total Debt
$74,960,000
Shares Out
201,954,184
Trailing EPS
$-0.04
Book Value
$0.38
ROE
-10.7%
ROA
-0.7%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 206,133,000 | -8,681,000 | -15,627,000 | 221,859,000 | 156,894,000 | 64,224,000 | 4,837,000 |
| Dec 2024 | 180,270,000 | -14,225,000 | -20,918,000 | 200,917,000 | 144,021,000 | 56,145,000 | 11,359,000 |
| Dec 2023 | 156,367,000 | -26,325,000 | -37,489,000 | 197,748,000 | 144,304,000 | 52,650,000 | -43,168,000 |
| Dec 2022 | 162,048,000 | -34,081,000 | -42,779,000 | 218,092,000 | 149,530,000 | 67,610,000 | -25,615,000 |
TTM Snapshot
Revenues TTM
$277,203,000
NetIncome TTM
$-6,783,000
OpCashFlow TTM
—
Assets (Latest)
$205,187,000
Forward EPS
$-0.01
Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)
max pain strike: $3.00 · spot: $1.94 · call volume: 218 · put volume: 270
Expected Move to 2026-12-18:
±$0.20
(10.31%) —
implied range
$1.74 –
$2.14
· ATM straddle on $2.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BWAY | Brainsway Ltd. | $366.29M | $9.11 | — |
| CV | CapsoVision, Inc | $356.50M | $6.65 | — |
| MOBI | Mobia Medical, Inc. | $419.80M | $12.61 | — |
| EMBC | Embecta Corp. | $348.46M | $6.15 | — |
| BRSYF | Brainsway Ltd. | $427.01M | $10.62 | — |
News headlines (Yahoo Finance, 1h cache)
Cerus Corporation to Participate in Upcoming Investor Conferences
2026-11-17 21:01 · Yahoo
Cerus Corporation Q3 2026 Earnings Call Summary
2026-11-03 13:30 · Yahoo
Cerus: 3 Key Takeaways for Long-Term Investors
2026-11-03 11:59 · Yahoo
Cerus (CERS) Q3 2026 Earnings Call Transcript
2026-11-03 10:03 · Yahoo
Cerus Corp (CERS) Q3 2026 Earnings Call Highlights: Revenue Climbs 10% as Adjusted EBITDA ...
2026-11-03 05:06 · Yahoo
Cerus Q3 Earnings Call Highlights
2026-11-03 00:14 · Yahoo
Cerus: Q3 Earnings Snapshot
2026-11-02 23:05 · Yahoo
Cerus Corporation Announces Third Quarter 2026 Financial Results
2026-11-02 21:05 · Yahoo
Cerus Corporation Announces Positive Topline Results from Phase 3 RedeS Trial of the INTERCEPT Blood System for Red Blood Cells
2026-11-02 21:00 · Yahoo
Cerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026
2026-10-19 20:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.